|
SELE expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.645700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.318400E-02 |
| Normal-vs-Stage2 |
5.342500E-03 |
| Normal-vs-Stage3 |
5.732200E-02 |
| Normal-vs-Stage4 |
1.132030E-01 |
| Stage1-vs-Stage2 |
2.494100E-02 |
| Stage1-vs-Stage3 |
3.967800E-01 |
| Stage1-vs-Stage4 |
4.651400E-01 |
| Stage2-vs-Stage3 |
2.082200E-02 |
| Stage2-vs-Stage4 |
1.129010E-01 |
| Stage3-vs-Stage4 |
8.299600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.506300E-02 |
| Normal-vs-AfricanAmerican |
9.403300E-03 |
| Normal-vs-Asian |
2.891500E-02 |
| Caucasian-vs-AfricanAmerican |
7.236200E-02 |
| Caucasian-vs-Asian |
7.552600E-01 |
| AfricanAmerican-vs-Asian |
1.987970E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.660300E-02 |
| Normal-vs-Female |
2.848400E-02 |
| Male-vs-Female |
7.786200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.103500E-02 |
| Normal-vs-Age(41-60Yrs) |
3.903600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.376120E-02 |
| Normal-vs-Age(81-100Yrs) |
9.723000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.661800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.853800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.908200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.012800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.377600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.634200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.667000E-01 |
| Classical-VS-Follicular |
2.605400E-01 |
| Classical-VS-Other |
3.222800E-03 |
| Classical-VS-Normal |
3.611900E-02 |
| Tall-VS-Follicular |
6.866400E-01 |
| Tall-VS-Other |
1.038000E-01 |
| Tall-VS-Normal |
4.376100E-02 |
| Follicular-VS-Other |
4.071700E-02 |
| Follicular-VS-Normal |
1.714430E-02 |
| Other-VS-Normal |
2.802100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.479930E-02 |
| Normal-vs-N1 |
2.406200E-02 |
| N0-vs-N1 |
8.425600E-01 |
|
|
